- Home
- LGL vs ENLV Comparison
LGL vs ENLV Comparison
Compare LGL & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGL
- ENLV
- Stock Information
- Founded
- LGL 1917
- ENLV 2005
- Country
- LGL United States
- ENLV Israel
- Employees
- LGL N/A
- ENLV 49
- Industry
- LGL Industrial Machinery/Components
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- LGL Technology
- ENLV Health Care
- Exchange
- LGL Nasdaq
- ENLV Nasdaq
- Market Cap
- LGL 32.4M
- ENLV 34.9M
- IPO Year
- LGL N/A
- ENLV 1995
- Fundamental
- Price
- LGL $6.04
- ENLV $1.64
- Analyst Decision
- LGL
- ENLV Strong Buy
- Analyst Count
- LGL 0
- ENLV 2
- Target Price
- LGL N/A
- ENLV $9.50
- AVG Volume (30 Days)
- LGL 5.4K
- ENLV 85.6K
- Earning Date
- LGL 11-12-2024
- ENLV 11-30-2024
- Dividend Yield
- LGL N/A
- ENLV N/A
- EPS Growth
- LGL N/A
- ENLV N/A
- EPS
- LGL 0.07
- ENLV N/A
- Revenue
- LGL $3,929,000.00
- ENLV N/A
- Revenue This Year
- LGL N/A
- ENLV N/A
- Revenue Next Year
- LGL N/A
- ENLV N/A
- P/E Ratio
- LGL $79.22
- ENLV N/A
- Revenue Growth
- LGL 599.11
- ENLV N/A
- 52 Week Low
- LGL $4.42
- ENLV $1.15
- 52 Week High
- LGL $6.76
- ENLV $4.59
- Technical
- Relative Strength Index (RSI)
- LGL 52.63
- ENLV 59.22
- Support Level
- LGL $5.70
- ENLV $1.38
- Resistance Level
- LGL $6.19
- ENLV $1.75
- Average True Range (ATR)
- LGL 0.26
- ENLV 0.11
- MACD
- LGL -0.02
- ENLV 0.00
- Stochastic Oscillator
- LGL 72.00
- ENLV 70.27
About LGL LGL Group Inc. (The)
LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.